250 results
8-K
EX-99.1
AORT
Artivion Inc
7 Jul 11
Entry into a Material Definitive Agreement
12:00am
surgeries from the long-term wear complications associated with current biological valves. We believe that the system may resolve the long standing … exchange. Vitality™ is a two-part valve platform for patients of all ages that can potentially overcome the challenges of long-term leaflet wear
8-K
EX-99.1
AORT
Artivion Inc
12 Feb 08
CryoLife Receives FDA 510(k) Clearance for SynerGraft® Processed Human Pulmonary Heart Valves
12:00am
this treatment option.”
At FDA’s request, CryoLife is planning a post-clearance study to seek evidence for the potential and implied long-term benefits … of the SynerGraft process. Data to be collected is expected to include long-term safety and hemodynamic function, immune response, and explant analysis
8-K
EX-99.1
llnytow0wzj4b0qfxr96
1 Apr 20
Results of Operations and Financial Condition
4:30pm
DEF 14A
7cpi120x3maaco
8 Apr 97
Definitive proxy
12:00am
8-K
EX-99.1
6md j76b27pok
3 Nov 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
r7zwx12a
6 May 24
Artivion Reports First Quarter 2024 Financial Results
4:14pm